BackLaboratorios Farmaceuticos Rovi, S.A. Overview
Laboratorios Farmaceuticos Rovi, S.A.

Laboratorios Farmaceuticos Rovi, S.A. P/E Ratio

Laboratorios Farmaceuticos Rovi, S.A. (LABFF) has a P/E ratio of 16.04, below the sector sector average of 30.66.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

16.04

P/E Ratio

16.04

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

Laboratorios Farmaceuticos Rovi, S.A. (LABFF) FAQ

As of the most recent data, LABFF shows a P/E ratio of 16.04. That is below the sector sector average of 30.66. Scroll down for historical charts and peer comparison views.

The its sector sector average P/E ratio is about 30.66. Laboratorios Farmaceuticos Rovi, S.A. is at 16.04, which is lower that average. That is roughly 47.7% below the sector mean. Use the comparison chart on this page to see how LABFF stacks up against individual peers as well.

Investors watch LABFF's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Laboratorios Farmaceuticos Rovi, S.A.'s latest reading is 16.04. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this p/e ratio page, Stockcircle has Laboratorios Farmaceuticos Rovi, S.A.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 16.04) with ownership activity and broader fundamentals.